647 related articles for article (PubMed ID: 25727550)
1. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model.
de Molon RS; Cheong S; Bezouglaia O; Dry SM; Pirih F; Cirelli JA; Aghaloo TL; Tetradis S
Bone; 2014 Nov; 68():11-9. PubMed ID: 25093262
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.
Soundia A; Hadaya D; Esfandi N; de Molon RS; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo T; Tetradis S
Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.
de Molon RS; Hsu C; Bezouglaia O; Dry SM; Pirih FQ; Soundia A; Cunha FQ; Cirelli JA; Aghaloo TL; Tetradis S
J Bone Miner Res; 2016 Aug; 31(8):1596-607. PubMed ID: 26950411
[TBL] [Abstract][Full Text] [Related]
5. RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.
Aghaloo TL; Cheong S; Bezouglaia O; Kostenuik P; Atti E; Dry SM; Pirih FQ; Tetradis S
J Bone Miner Res; 2014 Apr; 29(4):843-54. PubMed ID: 24115073
[TBL] [Abstract][Full Text] [Related]
6. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.
Williams DW; Lee C; Kim T; Yagita H; Wu H; Park S; Yang P; Liu H; Shi S; Shin KH; Kang MK; Park NH; Kim RH
Am J Pathol; 2014 Nov; 184(11):3084-93. PubMed ID: 25173134
[TBL] [Abstract][Full Text] [Related]
7. Antiresorptive-Type and Discontinuation-Timing Affect ONJ Burden.
Hadaya D; Soundia A; Gkouveris I; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
J Dent Res; 2021 Jul; 100(7):746-753. PubMed ID: 33478337
[TBL] [Abstract][Full Text] [Related]
8. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.
Kang B; Cheong S; Chaichanasakul T; Bezouglaia O; Atti E; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
J Bone Miner Res; 2013 Jul; 28(7):1631-40. PubMed ID: 23426919
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.
Kuroshima S; Yamashita J
Bone; 2013 Sep; 56(1):101-9. PubMed ID: 23727433
[TBL] [Abstract][Full Text] [Related]
10. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice.
Hayano H; Kuroshima S; Sasaki M; Tamaki S; Inoue M; Ishisaki A; Sawase T
Bone; 2020 Jun; 135():115308. PubMed ID: 32142911
[TBL] [Abstract][Full Text] [Related]
11. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
[TBL] [Abstract][Full Text] [Related]
12. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
Soundia A; Hadaya D; Chau Y; Gkouveris I; Bezouglaia O; Dry S; Pirih F; Aghaloo T; Tetradis S
Bone; 2021 Jul; 148():115945. PubMed ID: 33836308
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.
Kim JW; Cha IH; Kim SJ; Kim MR
Clin Implant Dent Relat Res; 2016 Apr; 18(2):281-91. PubMed ID: 25726720
[TBL] [Abstract][Full Text] [Related]
14. Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition.
Nagaoka Y; Kajiya H; Ozeki S; Ikebe T; Okabe K
J Dent Res; 2015 Apr; 94(4):594-601. PubMed ID: 25535203
[TBL] [Abstract][Full Text] [Related]
15. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
16. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
[TBL] [Abstract][Full Text] [Related]
19. Clinically Relevant Doses of Sclerostin Antibody Do Not Induce Osteonecrosis of the Jaw (ONJ) in Rats with Experimental Periodontitis.
Hadaya D; Gkouveris I; Soundia A; Bezouglaia O; Boyce RW; Stolina M; Dwyer D; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
J Bone Miner Res; 2019 Jan; 34(1):171-181. PubMed ID: 30184271
[TBL] [Abstract][Full Text] [Related]
20. Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2.
Nakagawa T; Ohta K; Kubozono K; Ishida Y; Naruse T; Takechi M; Kamata N
Arch Oral Biol; 2015 Apr; 60(4):557-65. PubMed ID: 25601046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
